STARLIX 180MG
STARLIX 180MG
Discontinued
DIN Number
02245440
Drug Class
Human
Market Date
Mar 5, 2002
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02245440
AIG Number0146561003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BX03 NATEGLINIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
NATEGLINIDEActive
Strength: 180 MG
Monograph: NATEGLINIDE